Lipocalin-2 contributes to experimental atherosclerosis in a stage-dependent manner.
Sign Up to like & getrecommendations! Published in 2018 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2018.06.015
Abstract: BACKGROUND AND AIMS Lipocalin-2 (Lcn2) is a glycoprotein which can be secreted by immune cells. Several studies in humans have suggested Lcn2 can be used as a biomarker for the detection of unstable atherosclerotic lesions,… read more here.
Keywords: lipocalin contributes; ldlr lcn2; atherosclerotic lesions; lcn2 mice ... See more keywords